GlassScriptPhysician profile
Dreama V Brar
NPI 1730386459
$16,659.46
in general payments reported to CMS, 2019-2025
74 companies · $3,228 in 2025
The $3,228 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,003 · 2020: $686 · 2021: $1,580 · 2022: $2,809 · 2023: $2,922 · 2024: $3,433 · 2025: $3,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,282 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,281.77 |
| Education | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,655.62 | 2019-2025 | Qulipta, Ubrelvy, Duopa |
| Biogen, INC. | $1,435.67 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Ucb, INC. | $1,226.68 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Novartis Pharmaceuticals Corporation | $936.31 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $928.20 | 2019-2025 | Ultomiris, Soliris |
| Sk Life Science, INC. | $655.24 | 2020-2025 | |
| Emd Serono, INC. | $628.25 | 2019-2025 | Mavenclad |
| Genentech USA, INC. | $492.35 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Genzyme Corporation | $444.70 | 2019-2024 | |
| Lilly USA, LLC | $410.58 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Lundbeck LLC | $388.68 | 2019-2025 | Rexulti, Vyepti |
| Neurelis, INC. | $362.54 | 2020-2025 | Valtoco |
| Grifols USA, LLC | $334.14 | 2019-2025 | Gamunex-C |
| Eisai INC. | $332.89 | 2019-2025 | |
| Tg Therapeutics, INC. | $317.57 | 2023-2025 |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $312.16 | 2019-2025 | Uplizna, Aimovig |
| Pfizer INC. | $297.66 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $294.71 | 2019-2024 | Epidiolex |
| Amneal Pharmaceuticals LLC | $293.01 | 2019-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Mdd US Operations, LLC | $266.92 | 2022-2025 | Gocovri, Gocovri |
| Csl Behring | $255.83 | 2019-2025 | Hizentra |
| Celgene Corporation | $230.15 | 2021-2025 | Zeposia |
| Ceribell, INC. | $227.53 | 2025 | Pocket Eeg Device |
| Teva Pharmaceuticals USA, INC. | $210.46 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Kyowa Kirin, INC. | $180.47 | 2019-2024 | Nourianz |
| Ani Pharmaceuticals, INC. | $180.39 | 2022-2025 | Purified Cortrophin Gel |
| Banner Life Sciences, LLC | $167.58 | 2021-2024 | |
| Harmony Biosciences LLC | $147.26 | 2022-2025 | Wakix |
| Axsome Therapeutics, INC. | $147.21 | 2023-2025 | Sunosi, Symbravo |
| Argenx US, INC. | $145.77 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Supernus Pharmaceuticals, INC. | $144.16 | 2019-2025 | Qelbree |
| Acadia Pharmaceuticals INC | $139.45 | 2019-2025 | Nuplazid |
| Insightec,INC | $135.63 | 2022 | |
| Livanova USA, INC. | $134.30 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $131.12 | 2021 | |
| Neurocrine Biosciences, INC. | $130.92 | 2019-2025 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $124.04 | 2019-2022 | |
| Catalyst Pharmaceuticals, INC. | $111.85 | 2019-2023 | Fycompa |
| Allergan, INC. | $109.00 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $107.13 | 2021-2025 | Wainua |
| Greenwich Biosciences, INC. | $101.30 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $81.12 | 2023-2024 | Aptiom |
| Corium, LLC | $80.14 | 2022-2023 | Adlarity |
| Merz Pharmaceuticals, LLC | $76.12 | 2022-2025 | Xeomin |
| Cycle Pharmaceuticals INC | $74.73 | 2024-2025 | Tascenso Odt, Tiopronin |
| Octapharma USA, INC. | $72.52 | 2023-2025 | Panzyga |
| Janssen Pharmaceuticals, INC | $67.66 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $64.27 | 2021-2024 | Onpattro |
| Acorda Therapeutics, INC | $58.68 | 2019-2024 | Inbrija, Ampyra |
| Mallinckrodt Hospital Products INC. | $56.85 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $53.78 | 2024-2025 | Ponvory |
| Avanir Pharmaceuticals, INC. | $53.35 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $52.71 | 2025 | Rexulti |
| Ultragenyx Pharmaceutical INC. | $52.52 | 2024-2025 | Dojolvi |
| Biohaven Pharmaceutical Holding Company LTD. | $51.24 | 2022 | |
| Horizon Therapeutics Plc | $45.63 | 2022-2023 | Uplizna |
| Abbott Laboratories | $37.43 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $37.42 | 2023 | Trudhesa |
| Tanabe Pharma America, INC. | $35.27 | 2019 | |
| Averitas Pharma INC. | $35.23 | 2025 | Qutenza |
| Adamas Pharmaceuticals, INC. | $33.46 | 2019-2020 | |
| Tersera Therapeutics LLC | $31.74 | 2022 | |
| Promius Pharma LLC | $31.67 | 2019 | |
| Upsher-Smith Laboratories LLC | $24.11 | 2022 | |
| Janssen Biotech, INC. | $22.44 | 2025 | |
| Akcea Therapeutics, INC. | $22.40 | 2019 | |
| Grt US Holding, INC. | $21.28 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.94 | 2022 | |
| Avion Pharmaceuticals | $18.44 | 2022 | |
| Boston Scientific Corporation | $16.43 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.75 | 2021 | |
| Ge Healthcare | $14.70 | 2025 | |
| Vertical Pharmaceuticals, LLC | $14.17 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dreama Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.